Diabetes Medications and Heart Failure
- 28 October 2014
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 130 (18) , 1565-1567
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 2013
- Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic PatientsJournal of the American Heart Association, 2013
- Renal and Cardiac Effects of DPP-4 Inhibitors – from Preclinical Development to Clinical ResearchKidney and Blood Pressure Research, 2012
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetesHeart, 2004
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974